17 January 2022 - trading update
The AIM-listed supplier of instruments for minimally invasive surgery has announced a trading statement for the year ending 31 December 2021. The company has suffered from delays and cancellations of operations during the pandemic although it is pleasing to see that revenues in the second half of 2021 were 16% higher than the first half. Revenues for the full year are therefore expected to be £9.1m compared with £6.3m in 2020 and £10.7m in 2019. The group expects to report a small adjusted loss before tax for 2021. At the year . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
